Until recently, scientists have not known how often brucellosis is mistaken for malaria or other febrile illnesses, but new research from the Texas A&M College of Veterinary Medicine and Biomedical Sciences (VMBS) has discovered that as many as 7 million people worldwide may receive a misdiagnosis each year — vastly increasing the number of people estimated to have the disease.

A team of researchers combined computational and biological approaches and identified a molecular signature for the elusive neural stem cells responsible for generating new neurons in the adult brain.

About The Study: This retrospective cohort study found that taking glucagon-like peptide-1 receptor agonists (GLP-1RAs) was associated with a reduced overall risk of cancer, including lower risks of endometrial, ovarian, and meningioma cancers, among patients with obesity or overweight. However, taking GLP-1RAs may be associated with an increased risk of kidney cancer, highlighting the need for longer-term follow-up to clarify the underlying mechanisms and clinical implications of these findings.

About The Study: In this secondary analysis of a randomized clinical trial, a telephone-based weight loss intervention induced significant weight loss in patients with breast cancer with overweight and obesity across demographic and treatment factors. Further follow-up of the Breast Cancer Weight Loss trial will evaluate whether the weight loss intervention improves disease outcomes.

A new study led by Mass General Brigham found that AI-powered ambient documentation technologies significantly reduce physician burnout—by 21.2% at Mass General Brigham and with a 30.7% improvement in documentation-related wellbeing at Emory Healthcare —while also freeing up time for more meaningful patient interactions. Providers reported feeling more connected to their work, reclaiming personal time, and experiencing a renewed joy in practicing medicine, highlighting the transformative potential of this technology in improving clinician wellbeing and patient care.

Research out of the University of New Hampshire shows that communities that were easier for people to lace up and get out for a walk during the COVID-19 pandemic also helped lower the impact of mental health issues, like stress and anxiety.

A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy everolimus to standard carboplatin chemotherapy extends the time before disease progression in patients with advanced triple-negative breast cancer (TNBC), one of the most aggressive and hard-to-treat forms of breast cancer.